FiercePharma  Oct 12  Comment 
Novartis adds new chemo-topping data to Zykadia marketing arsenal chelfand Wed, 10/12/2016 - 08:58
FiercePharma  Oct 10  Comment 
Novartis sponsors Queen Latifah's mom-inspired heart failure awareness push aliu Mon, 10/10/2016 - 08:13
FierceBiotech  Oct 10  Comment 
Novartis edges closer to market, rival Ibrance with latest PhIII data update badams Mon, 10/10/2016 - 04:00
newratings.com  Oct 9  Comment 
BASEL (dpa-AFX) - Novartis (NVS) announced updated results from Phase II study (ASCEND-3), which demonstrated that anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients taking Zykadia (ceritinib). Results were...
newratings.com  Oct 8  Comment 
BASEL (dpa-AFX) - Novartis (NVS) announced data from the Phase III COMBI-v study showing an overall survival and a progression-free survival benefit for patients with BRAF V600 mutation-positive advanced melanoma when treated first-line with the...
The Hindu Business Line  Oct 8  Comment 
Novartis' ribociclib to take on Pfizer blockbuster Ibrance
newratings.com  Oct 8  Comment 
Novartis breakthrough therapy LEE011 plus letrozole demonstrates superior progression-free survival as first-line treatment for HR+/HER2- advanced breast cancer compared to a standard of care Novartis International AG / Novartis breakthrough...
FiercePharma  Oct 7  Comment 
UDPATE2: Novartis' Ibrance challenger cuts breast cancer progression risk by 44% chelfand Fri, 10/07/2016 - 18:57


Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki